ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Health Organizations Endorse “Patients’ Rights” Document

November 17, 1995

NCI Cooperative Group Trials Approved Last Month By CTEP

March 26, 2010

NCI Breast Tissue Registry Available To Researchers

March 24, 1995

Hopkins Oncology Center Renamed To Honor Sidney Kimmel

May 10, 2002

Bill Would Require Medicare to Reimburse Costs of Trials

March 7, 1997

CT Scan Can Spare Surgery In Head And Neck Cancer

November 25, 2005